Page 1 of Clinical Trials for Tumor, 34405 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
Last Updated: October 17, 2011
Condition(s): Breast Cancer
2
Completed
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
Last Updated: May 1, 2012
Condition(s): Adrenocortical Carcinoma; Breast Cancer; Colorectal Cancer; Gastrointestinal Cancer; Kidney Cancer; Liver Cancer; Melanoma (Skin); Ovarian Cancer; Pancreatic Cancer; Sarcoma
3
Recruiting
MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Last Updated: April 26, 2011
Condition(s): Breast Cancer; Unspecified Adult Solid Tumor, Protocol Specific
4
Recruiting
Tumor Cell Vaccines and ISCOMATRIX(Trademark) With Chemotherapy After Tumor Removal
Last Updated: March 27, 2012
Condition(s): Sarcoma; Melanoma; Epithelial Malignancies; Pleural Malignancy
5
Recruiting
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
Last Updated: April 10, 2012
Condition(s): Lung Cancer; Esophageal Cancer; Malignant Pleural Mesothelioma; Thymoma; Thymic Carcinoma
6
Active, not recruiting
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Last Updated: May 22, 2012
Condition(s): Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer
7
Recruiting
Tumor Cell Vaccines With ISCOMATRIX(Trademark) Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Last Updated: April 24, 2012
Condition(s): Mesolthelioma; Esophageal Cancer; Lung Cancer
8
Active, not recruiting
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
Last Updated: May 22, 2012
Condition(s): Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer
9
Recruiting
Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum
Last Updated: March 14, 2012
Condition(s): Sarcoma; Melanoma; Epithelial Malignancies; Pleural Malignancies
10
Active, not recruiting
Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Last Updated: February 6, 2009
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
11
Recruiting
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Last Updated: February 24, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Malignant Tumor of Peritoneum
12
Active, not recruiting
Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Last Updated: March 14, 2012
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms; Primary Peritoneal Neoplasms
13
Recruiting
Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors
Last Updated: March 14, 2012
Condition(s): Solid Tumors; Brain Tumors; Brain Metastases
14
Recruiting
Screening Methods for Finding Ovarian Cancer
Last Updated: February 25, 2011
Condition(s): Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Hereditary Breast and Ovarian Cancer Syndrome; Ovarian Cancer; Sarcoma; Uterine Fibroids; Vaginal Cancer; Vulvar Cancer
15
Completed
Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor
Last Updated: April 23, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
16
Completed
AZD2171 and Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
Last Updated: January 18, 2011
Condition(s): Colorectal Cancer; Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
17
Not yet recruiting
Early Detection of Cancers in Low Resource Countries
Last Updated: August 8, 2010
Condition(s): Breast Neoplasms; Uterine Cervical Neoplasms; Ovarian Neoplasms; Endometrial Neoplasms
18
Recruiting
Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
Last Updated: January 6, 2012
Condition(s): Brain and Central Nervous System Tumors
19
Not yet recruiting
Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies
Last Updated: March 28, 2012
Condition(s): Malignant Solid Tumour; Breast Cancer Nos Metastatic Recurrent; Neuropathy
20
Recruiting
Genomic Testing for Primary Breast Cancer
Last Updated: March 2, 2012
Condition(s): Breast Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Tumor

Page 1 of Clinical Trials for Tumor, 34405 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About